The association between coeliac disease and cardiovascular disease

L. Wei, E. Spiers, N. Reynolds, S. Walsh, T. Fahey, T. M. MacDonald

    Research output: Contribution to journalArticle

    43 Citations (Scopus)

    Abstract

    Background

    Coeliac disease is more prevalent than was previously thought. The association between coeliac disease and cardiovascular outcome is not clear.

    Aim

    To investigate whether coeliac disease patients have an increased risk of cardiovascular events.

    Methods

    A community-based cohort study using a record-linkage database. Three hundred and sixty-seven coeliac patients identified by a positive antiendomysial antibody test or a diagnosis with small bowel biopsy, and 5537 subjects who were tested and had a negative coeliac immunology, were included in the study.

    Results

    The crude rates of cardiovascular events were 9.5 per 1000 person-years (95% CI: 4.4-14.6) in the coeliac cohort and 8.9 per 1000 person-years (95% CI: 7.6-10.3) in the antiendomysial antibody-negative cohort. Compared with the antiendomysial antibody-negative cohort, the adjusted relative risk of cardiovascular events for coeliac cohort was 1.9 (95% CI: 1.00-3.60). When we excluded patients who had previous hospitalization for cardiovascular disease, the adjusted relative risk was 2.5 (95% CI: 1.22-5.01). The use of any cardiovascular drugs prior to and after entry to the study were 36% and 29% for the coeliac cohort (P = 0.05), and 34% and 26% for the antiendomysial antibody-negative cohort (P < 0.01).

    Conclusion

    Our findings suggest that coeliac disease seems to be associated with an increased risk of cardiovascular outcome.

    Original languageEnglish
    Pages (from-to)514-519
    Number of pages6
    JournalAlimentary Pharmacology & Therapeutics
    Volume27
    Issue number6
    DOIs
    Publication statusPublished - 15 Mar 2008

    Keywords

    • VASCULAR-DISEASE
    • FOLIC-ACID
    • HOMOCYSTEINE
    • RISK
    • HYPERTENSION
    • COHORT

    Cite this

    Wei, L. ; Spiers, E. ; Reynolds, N. ; Walsh, S. ; Fahey, T. ; MacDonald, T. M. / The association between coeliac disease and cardiovascular disease. In: Alimentary Pharmacology & Therapeutics. 2008 ; Vol. 27, No. 6. pp. 514-519.
    @article{f278254d5ec64c9e80ff2287767a2e08,
    title = "The association between coeliac disease and cardiovascular disease",
    abstract = "BackgroundCoeliac disease is more prevalent than was previously thought. The association between coeliac disease and cardiovascular outcome is not clear.AimTo investigate whether coeliac disease patients have an increased risk of cardiovascular events.MethodsA community-based cohort study using a record-linkage database. Three hundred and sixty-seven coeliac patients identified by a positive antiendomysial antibody test or a diagnosis with small bowel biopsy, and 5537 subjects who were tested and had a negative coeliac immunology, were included in the study.ResultsThe crude rates of cardiovascular events were 9.5 per 1000 person-years (95{\%} CI: 4.4-14.6) in the coeliac cohort and 8.9 per 1000 person-years (95{\%} CI: 7.6-10.3) in the antiendomysial antibody-negative cohort. Compared with the antiendomysial antibody-negative cohort, the adjusted relative risk of cardiovascular events for coeliac cohort was 1.9 (95{\%} CI: 1.00-3.60). When we excluded patients who had previous hospitalization for cardiovascular disease, the adjusted relative risk was 2.5 (95{\%} CI: 1.22-5.01). The use of any cardiovascular drugs prior to and after entry to the study were 36{\%} and 29{\%} for the coeliac cohort (P = 0.05), and 34{\%} and 26{\%} for the antiendomysial antibody-negative cohort (P < 0.01).ConclusionOur findings suggest that coeliac disease seems to be associated with an increased risk of cardiovascular outcome.",
    keywords = "VASCULAR-DISEASE, FOLIC-ACID, HOMOCYSTEINE, RISK, HYPERTENSION, COHORT",
    author = "L. Wei and E. Spiers and N. Reynolds and S. Walsh and T. Fahey and MacDonald, {T. M.}",
    year = "2008",
    month = "3",
    day = "15",
    doi = "10.1111/j.1365-2036.2007.03594.x",
    language = "English",
    volume = "27",
    pages = "514--519",
    journal = "Alimentary Pharmacology & Therapeutics",
    issn = "0269-2813",
    publisher = "Wiley",
    number = "6",

    }

    The association between coeliac disease and cardiovascular disease. / Wei, L.; Spiers, E.; Reynolds, N.; Walsh, S.; Fahey, T.; MacDonald, T. M.

    In: Alimentary Pharmacology & Therapeutics, Vol. 27, No. 6, 15.03.2008, p. 514-519.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - The association between coeliac disease and cardiovascular disease

    AU - Wei, L.

    AU - Spiers, E.

    AU - Reynolds, N.

    AU - Walsh, S.

    AU - Fahey, T.

    AU - MacDonald, T. M.

    PY - 2008/3/15

    Y1 - 2008/3/15

    N2 - BackgroundCoeliac disease is more prevalent than was previously thought. The association between coeliac disease and cardiovascular outcome is not clear.AimTo investigate whether coeliac disease patients have an increased risk of cardiovascular events.MethodsA community-based cohort study using a record-linkage database. Three hundred and sixty-seven coeliac patients identified by a positive antiendomysial antibody test or a diagnosis with small bowel biopsy, and 5537 subjects who were tested and had a negative coeliac immunology, were included in the study.ResultsThe crude rates of cardiovascular events were 9.5 per 1000 person-years (95% CI: 4.4-14.6) in the coeliac cohort and 8.9 per 1000 person-years (95% CI: 7.6-10.3) in the antiendomysial antibody-negative cohort. Compared with the antiendomysial antibody-negative cohort, the adjusted relative risk of cardiovascular events for coeliac cohort was 1.9 (95% CI: 1.00-3.60). When we excluded patients who had previous hospitalization for cardiovascular disease, the adjusted relative risk was 2.5 (95% CI: 1.22-5.01). The use of any cardiovascular drugs prior to and after entry to the study were 36% and 29% for the coeliac cohort (P = 0.05), and 34% and 26% for the antiendomysial antibody-negative cohort (P < 0.01).ConclusionOur findings suggest that coeliac disease seems to be associated with an increased risk of cardiovascular outcome.

    AB - BackgroundCoeliac disease is more prevalent than was previously thought. The association between coeliac disease and cardiovascular outcome is not clear.AimTo investigate whether coeliac disease patients have an increased risk of cardiovascular events.MethodsA community-based cohort study using a record-linkage database. Three hundred and sixty-seven coeliac patients identified by a positive antiendomysial antibody test or a diagnosis with small bowel biopsy, and 5537 subjects who were tested and had a negative coeliac immunology, were included in the study.ResultsThe crude rates of cardiovascular events were 9.5 per 1000 person-years (95% CI: 4.4-14.6) in the coeliac cohort and 8.9 per 1000 person-years (95% CI: 7.6-10.3) in the antiendomysial antibody-negative cohort. Compared with the antiendomysial antibody-negative cohort, the adjusted relative risk of cardiovascular events for coeliac cohort was 1.9 (95% CI: 1.00-3.60). When we excluded patients who had previous hospitalization for cardiovascular disease, the adjusted relative risk was 2.5 (95% CI: 1.22-5.01). The use of any cardiovascular drugs prior to and after entry to the study were 36% and 29% for the coeliac cohort (P = 0.05), and 34% and 26% for the antiendomysial antibody-negative cohort (P < 0.01).ConclusionOur findings suggest that coeliac disease seems to be associated with an increased risk of cardiovascular outcome.

    KW - VASCULAR-DISEASE

    KW - FOLIC-ACID

    KW - HOMOCYSTEINE

    KW - RISK

    KW - HYPERTENSION

    KW - COHORT

    U2 - 10.1111/j.1365-2036.2007.03594.x

    DO - 10.1111/j.1365-2036.2007.03594.x

    M3 - Article

    VL - 27

    SP - 514

    EP - 519

    JO - Alimentary Pharmacology & Therapeutics

    JF - Alimentary Pharmacology & Therapeutics

    SN - 0269-2813

    IS - 6

    ER -